These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21315927)

  • 1. Designing drugs to avoid toxicity.
    Smith GF
    Prog Med Chem; 2011; 50():1-47. PubMed ID: 21315927
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction: Human metabolites in safety testing (MIST) issue.
    Guengerich FP
    Chem Res Toxicol; 2009 Feb; 22(2):237-8. PubMed ID: 19216576
    [No Abstract]   [Full Text] [Related]  

  • 3. Cationic amphiphilic drugs and phospholipid storage disorder.
    Kodavanti UP; Mehendale HM
    Pharmacol Rev; 1990 Dec; 42(4):327-54. PubMed ID: 2080227
    [No Abstract]   [Full Text] [Related]  

  • 4. The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.
    Testa B; Krämer SD
    Chem Biodivers; 2009 May; 6(5):591-684. PubMed ID: 19479846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.
    Zolk O; Fromm MF
    Clin Pharmacol Ther; 2011 Jun; 89(6):798-805. PubMed ID: 21471963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory perspective on issues and approaches in characterizing human metabolites.
    Davis-Bruno KL; Atrakchi A
    Chem Res Toxicol; 2006 Dec; 19(12):1561-3. PubMed ID: 17173368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on incidence and nature of testicular toxicity findings in pharmaceutical development survey: a pathologist's perspective.
    Creasy DM
    Birth Defects Res B Dev Reprod Toxicol; 2011 Dec; 92(6):508-10. PubMed ID: 21818841
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety assessment of drug metabolites: Characterization of chemically stable metabolites.
    Humphreys WG; Unger SE
    Chem Res Toxicol; 2006 Dec; 19(12):1564-9. PubMed ID: 17173369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on epigenetics and its relevance to adverse drug reactions.
    Kacevska M; Ivanov M; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2011 Jun; 89(6):902-7. PubMed ID: 21508940
    [No Abstract]   [Full Text] [Related]  

  • 11. Elucidating mechanisms of drug-induced toxicity.
    Liebler DC; Guengerich FP
    Nat Rev Drug Discov; 2005 May; 4(5):410-20. PubMed ID: 15864270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.
    Siraki AG; Chevaldina T; Moridani MY; O'Brien PJ
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):118-25. PubMed ID: 14982155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of drugs in the practice of medicine].
    Cremomesi E
    Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(6):484-94. PubMed ID: 796933
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrating metabolism and toxicity in multi-organ systems.
    Madden S; Bach PH
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):66-72. PubMed ID: 11727325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pharmacokinetics and metabolism in drug discovery and development.
    Lin JH; Lu AY
    Pharmacol Rev; 1997 Dec; 49(4):403-49. PubMed ID: 9443165
    [No Abstract]   [Full Text] [Related]  

  • 16. Aging and the liver.
    Kitani K
    Prog Liver Dis; 1990; 9():603-23. PubMed ID: 2156317
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug targeting via retrometabolic approaches.
    Bodor N; Buchwald P
    Pharmacol Ther; 1997; 76(1-3):1-27. PubMed ID: 9535166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurrection men dig through the drug graveyard: ARYx revives problem blockbuster drugs.
    Wolfson W
    Chem Biol; 2005 Nov; 12(11):1155-6. PubMed ID: 16298292
    [No Abstract]   [Full Text] [Related]  

  • 19. Can we rationally design promiscuous drugs?
    Hopkins AL; Mason JS; Overington JP
    Curr Opin Struct Biol; 2006 Feb; 16(1):127-36. PubMed ID: 16442279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic actions of antimicrobial agents in host cell membranes.
    Adams HR
    J Am Vet Med Assoc; 1984 Nov; 185(10):1127-30. PubMed ID: 6392241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.